Total Credits: 1.0
Coronary intervention, or angioplasty, has been in practice for 40 years. Dr. Alphonse Ambrosia reviews the current guidelines for determining the right treatment for each patient.
Educational Objectives:
Distinguish the role of coronary imaging and physiology in percutaneous coronary interventions
Compare stent technology with bioabsorbable polymers
Differentiate bioabsorbable stent technology and its future role in percutaneous coronary interventions
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Osteopathic Association (AOA). The Arizona Osteopathic Medical Association (AOMA) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.
GRIEVANCE POLICY: The AOMA strives to provide continuing medical education programs to fulfill the needs of the attendees and to meet the AOA Uniform Guidelines and AOA Accreditation Requirements. Comments, questions, or complaints should be forwarded to AOMA Executive Director Josephine Zammuto, by calling the AOMA Office at 602-266-6699 or by mail to AOMA, 5150 N. 16th Street, Suite A-122, Phoenix, AZ 85016, or by email to info@az-osteo.org.
| Course Materials (5.00 MB) | 75 Pages | Available after Purchase |
Alphonse M. Ambrosia, DO, FACC is an interventional cardiologist specializing in coronary artery disease, heart failure, hypertensive heart disease, stroke & carotid artery disease, coronary angiography & angioplasty, carotid angioplasty & stenting, TEE, PFO closure, renal artery angioplasty & stenting, and TAVI procedure. Board certified in cardiovascular disease and interventional cardiology, Dr. Ambrosia is a Fellow of the American College of Cardiology. He received his osteopathic medical degree from the College of Osteopathic Medicine of the Pacific. Dr. Ambrosia practices with Cardiovascular Associates of Mesa in Mesa, Arizona. “My hope, as my patient, is that we will be able to bring you the most advanced coronary and cardiac interventional techniques, the most advanced technology in the hospital and office, in a setting that will be relaxed, and that will allow you to have all your concerns addressed.”
Dr. Ambrosia is a member of the speakers bureau for the following companies: Boston Scientific, Medtronics Vascular, Philips/Volcano Corp, Novartis.
| 5 |
|
| 4 |
|
| 3 |
|
| 2 |
|
| 1 |
|